Labels
Breast Cancers
(148)
Lung Cancers
(75)
Genitourinary Cancers
(73)
Gastrointestinal Cancers
(67)
Gynecological Cancers
(58)
Head and Neck Cancers
(50)
Cutaneous Cancers
(21)
Central Nervous System Cancers
(11)
Tuesday, 26 November 2013
FDA approves Nexavar for advanced thyroid cancer
The US Food and Drug Administration (FDA) has approved Nexavar (sorafenib) to treat some people with advanced thyroid cancer. The drug was already on the market for treating some types of kidney cancer and liver cancer. The new approval is for treating differentiated thyroid cancer – the most common type – that has come back after treatment or that has spread to other parts of the body (metastasized), and is no longer responding to radioactive iodine treatment. Read more here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment